6 A 2017 meta-analysis of randomised controlled trials found that myo-inositol supplementation significantly reduced fasting insulin levels and the homeostasis model assessment of insulin resistance (HOMA-IR) index in women with PCOS
We also discuss long-term implications for T2DM care, weight management and, ultimately, cardiorenal disease prevention in patients with T2DM and/or overweight or obesity
When used in combination with a balanced diet and regular physical activity, GLP-1 injections can assist individuals in losing weight by improving metabolic function and reducing the risk of developing type 2 diabetes
They can also be used to prevent and treat endocrine disorders or metabolic diseases such as polycystic ovary syndrome (PCOS), obesity, and non-alcoholic fatty liver disease (NAFLD) (135)
Key Takeaways KLOW combines four peptides for a powerful, synergistic effect : Unlike single-peptide therapies that target one issue, KLOW's blend works as a team to reduce inflammation, repair tissue, and support cellular health simultaneously, creating a more comprehensive healing response